The potential molecular mechanisms that result in the upregulation of YB-1 may contribute to decreased intracellular androgen accumulation, thus weaning PCa off androgen dependency and upregulating tumor survival (28). The gene discussed is YBX1; the disease is posterior cortical atrophy.